DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 213 filers reported holding DEPOMED INC in Q3 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $120,000 | -28.1% | 17,930 | -29.2% | 0.01% | -25.0% |
Q1 2018 | $167,000 | -11.2% | 25,320 | +8.3% | 0.01% | -11.1% |
Q4 2017 | $188,000 | +39.3% | 23,370 | 0.0% | 0.01% | +28.6% |
Q3 2017 | $135,000 | -14.0% | 23,370 | +59.4% | 0.01% | -12.5% |
Q2 2017 | $157,000 | -11.3% | 14,660 | +4.2% | 0.01% | 0.0% |
Q1 2017 | $177,000 | -30.3% | 14,070 | 0.0% | 0.01% | -33.3% |
Q4 2016 | $254,000 | -25.1% | 14,070 | +3.8% | 0.01% | -29.4% |
Q3 2016 | $339,000 | +29.4% | 13,560 | +1.4% | 0.02% | +21.4% |
Q2 2016 | $262,000 | +45.6% | 13,370 | +3.3% | 0.01% | +16.7% |
Q1 2016 | $180,000 | -18.6% | 12,940 | +6.1% | 0.01% | -25.0% |
Q4 2015 | $221,000 | -51.3% | 12,200 | -54.7% | 0.02% | -5.9% |
Q3 2015 | $454,000 | +86.1% | 26,950 | +137.2% | 0.02% | -5.6% |
Q2 2015 | $244,000 | -2.0% | 11,360 | +2.3% | 0.02% | -5.3% |
Q1 2015 | $249,000 | +4.6% | 11,100 | -25.0% | 0.02% | +18.8% |
Q4 2014 | $238,000 | +5.8% | 14,800 | 0.0% | 0.02% | -5.9% |
Q3 2014 | $225,000 | – | 14,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |